Xometry (NASDAQ:XMTR) Given New $38.00 Price Target at JPMorgan Chase & Co.

Xometry (NASDAQ:XMTR) had its target price boosted by JPMorgan Chase & Co. from $36.00 to $38.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other research firms also recently commented on XMTR. Cantor Fitzgerald increased their price objective on shares of Xometry from $20.00 to $21.00 and gave the company an “underweight” rating in a report on Wednesday, May 7th. Citigroup cut their price objective on shares of Xometry from $46.00 to $39.00 and set a “buy” rating for the company in a report on Thursday, February 27th. UBS Group increased their price objective on shares of Xometry from $33.00 to $35.00 and gave the company a “neutral” rating in a report on Wednesday, May 7th. The Goldman Sachs Group increased their price objective on shares of Xometry from $30.00 to $33.00 and gave the company a “buy” rating in a report on Thursday, May 8th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $42.00 price objective on shares of Xometry in a report on Monday, February 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Xometry currently has an average rating of “Moderate Buy” and a consensus target price of $35.78.

Xometry Stock Up 5.2%

XMTR opened at $34.33 on Tuesday. Xometry has a twelve month low of $11.08 and a twelve month high of $45.33. The company has a quick ratio of 4.55, a current ratio of 4.59 and a debt-to-equity ratio of 0.90. The company has a 50-day moving average price of $27.33 and a 200 day moving average price of $31.13. The company has a market cap of $1.74 billion, a PE ratio of -32.69 and a beta of 0.71.

Insider Transactions at Xometry

In other news, Director Emily Rollins sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $20.66, for a total transaction of $41,320.00. Following the completion of the sale, the director now owns 16,146 shares in the company, valued at $333,576.36. This trade represents a 11.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Randolph Altschuler sold 9,331 shares of the firm’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $25.16, for a total transaction of $234,767.96. Following the sale, the chief executive officer now owns 328,934 shares of the company’s stock, valued at $8,275,979.44. This represents a 2.76% decrease in their position. The disclosure for this sale can be found here. Insiders sold 24,644 shares of company stock worth $666,660 in the last 90 days. Insiders own 9.66% of the company’s stock.

Hedge Funds Weigh In On Xometry

A number of hedge funds have recently made changes to their positions in the stock. Rhumbline Advisers boosted its position in shares of Xometry by 2.2% during the 1st quarter. Rhumbline Advisers now owns 60,682 shares of the company’s stock worth $1,512,000 after purchasing an additional 1,315 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Xometry by 26.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company’s stock worth $11,281,000 after purchasing an additional 95,154 shares during the period. Sylebra Capital LLC boosted its position in shares of Xometry by 2.6% during the 1st quarter. Sylebra Capital LLC now owns 1,881,624 shares of the company’s stock worth $46,890,000 after purchasing an additional 46,874 shares during the period. Petrus Trust Company LTA purchased a new position in shares of Xometry during the 1st quarter worth approximately $649,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Xometry by 7.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,054 shares of the company’s stock worth $649,000 after purchasing an additional 1,877 shares during the period. Hedge funds and other institutional investors own 97.31% of the company’s stock.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.